Drugmaker's Opioid Probe Costs Not Covered, 9th Circ. Says
U.S. Specialty Insurance Co. has no obligation to cover more than $4 million in costs an opioid drugmaker said it incurred while responding to a U.S. Department of Justice investigation, the...To view the full article, register now.
Already a subscriber? Click here to view full article